| Measured mood profile | In healthy young women, no improvement in mood compared with placebo was found after three weeks of L-tryptophan at the studied doses of 1 to 5 g per day. | 2/4 LowPrecision of the estimate: Small sample, incomplete or imprecise comparative estimate. Consistency of results: No basis for a separate downgrade. Applicability to the stated group: The measurement directly addresses the specified narrow PICO. Possible publication bias: No specific data support a separate downgrade. Study methods: Small studies and limitations in analysis or reporting. | 11 trialSupplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects ↗ | 17 healthy young women | - Supplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects ↗
|
|---|
| Running to exhaustion at 100% VO₂max | In trained men, the duration of intense running to exhaustion after 1.2 g of L-tryptophan over a day did not clearly differ from placebo. | 2/4 LowPrecision of the estimate: Small sample, incomplete or imprecise comparative estimate. Consistency of results: No basis for a separate downgrade. Applicability to the stated group: The measurement directly addresses the specified narrow PICO. Possible publication bias: No specific data support a separate downgrade. Study methods: Small studies and limitations in analysis or reporting. | 11 trialL-tryptophan supplementation does not improve running performance ↗ | 49 trained men | - L-tryptophan supplementation does not improve running performance ↗
|
|---|
| Beck questionnaire | In the study of eight participants, the mean Beck questionnaire score was 10.9 with tryptophan and 8.3 with placebo; no statistical comparison is reported in the available abstract. These means do not establish a benefit, deterioration or an independent effect of tryptophan.In the study of eight participants, the mean Beck questionnaire score was 10.9 with tryptophan and 8.3 with placebo; no statistical comparison is reported in the available abstract. | 1/4 Very lowOnly eight completers; the available abstract provides no variability, confidence interval or paired statistical comparison. The weight-loss programme ran alongside supplementation; information on the periods, washout and full report is limited. | 11 studyL-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗ | 8 adult participants with obesity and carbohydrate cravings who completed the study | - L-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗
|
|---|
| SCL-90 scale | In the study of eight participants, the mean SCL-90 score was 64.2 with tryptophan and 54.6 with placebo; no statistical comparison is reported in the available abstract. These means do not establish a benefit, deterioration or an independent effect of tryptophan.In the study of eight participants, the mean SCL-90 score was 64.2 with tryptophan and 54.6 with placebo; no statistical comparison is reported in the available abstract. | 1/4 Very lowOnly eight completers; the available abstract provides no variability, confidence interval or paired statistical comparison. The weight-loss programme ran alongside supplementation; information on the periods, washout and full report is limited. | 11 studyL-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗ | 8 adult participants with obesity and carbohydrate cravings who completed the study | - L-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗
|
|---|
| Overall POMS mood score | In the study of eight participants, the mean score was 52 with tryptophan and 43 with placebo; no statistical comparison is reported in the available abstract. These means do not establish a benefit, deterioration or an independent effect of tryptophan.In the study of eight participants, the mean score was 52 with tryptophan and 43 with placebo; no statistical comparison is reported in the available abstract. | 1/4 Very lowOnly eight completers; the available abstract provides no variability, confidence interval or paired statistical comparison. The weight-loss programme ran alongside supplementation; information on the periods, washout and full report is limited. | 11 studyL-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗ | 8 adult participants with obesity and carbohydrate cravings who completed the study | - L-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗
|
|---|
| Peak anaerobic power | In the stationary-bike experiment, peak anaerobic power was higher after L-tryptophan than after placebo; the size of the difference is not given in the available abstract. | 2/4 LowOne crossover trial with 20 participants; a numerical comparative estimate of power and a paired confidence interval are unavailable. Randomized order and blinding are reported; washout, allocation concealment, period effects and completeness of reporting are not confirmed. | 11 studyL-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗ | 20 healthy young, physically active men | - L-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗
|
|---|
| Mean anaerobic power | In the stationary-bike experiment, mean anaerobic power was higher after L-tryptophan than after placebo; the size of the difference is not given in the available abstract. | 2/4 LowOne crossover trial with 20 participants; a numerical comparative estimate of power and a paired confidence interval are unavailable. Randomized order and blinding are reported; washout, allocation concealment, period effects and completeness of reporting are not confirmed. | 11 studyL-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗ | 20 healthy young, physically active men | - L-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗
|
|---|
| Power during the final 20 minutes | During the final 20 minutes of the cycling protocol, power was higher after L-tryptophan than after placebo; the size of the difference is not given in the available abstract. | 2/4 LowOne crossover trial with 20 participants; a numerical comparative estimate of power and a paired confidence interval are unavailable. Randomized order and blinding are reported; washout, allocation concealment, period effects and completeness of reporting are not confirmed. | 11 studyL-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗ | 20 healthy young, physically active men | - L-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗
|
|---|
| Distance during the final 20 minutes | During the final 20 minutes of the cycling protocol, participants covered an average of 12 526 m with L-tryptophan and 11 959 m with placebo: the difference between the means was 567 m. | 1/4 Very lowOne small crossover study; a paired confidence interval for distance was not extracted. The specific laboratory protocol and unknown exact dose limit applicability; washout and reporting details are not fully established. | 11 studyL-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗ | 20 healthy young, physically active men | - L-tryptophan supplementation can decrease fatigue perception during an aerobic exercise with supramaximal intercalated anaerobic bouts in young healthy men. ↗
|
|---|
| Body weight | In 17 healthy young women taking 1–5 g of L-tryptophan per day for 21 days in each period, no effect on body weight compared with placebo was found. | 2/4 LowOne small study of 17 women; exact comparative estimates and a confidence interval for weight are not reported. Information on allocation and period effects is limited; the result applies to the group studied. | 11 studySupplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects ↗ | 17 healthy Japanese women aged 18–26 years | - Supplementing healthy women with up to 5.0 g/d of L-tryptophan has no adverse effects ↗
|
|---|
| Change in body weight | In the weight-loss programme, eight participants lost an average of 2.3 kg during the tryptophan period and 1.14 kg during the placebo period; a comparative estimate is not reported in the available abstract. These means do not establish a benefit, deterioration or an independent effect of tryptophan.In the weight-loss programme, eight participants lost an average of 2.3 kg during the tryptophan period and 1.14 kg during the placebo period; a comparative estimate is not reported in the available abstract. | 1/4 Very lowOnly eight completers; the available abstract provides no variability, confidence interval or paired statistical comparison. The weight-loss programme ran alongside supplementation; information on the periods, washout and full report is limited. | 11 studyL-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗ | 8 adult participants with obesity and carbohydrate cravings who completed the study | - L-tryptophan does not increase weight loss in carbohydrate-craving obese subjects. ↗
|
|---|
| Gastrointestinal symptom scale | On the specified diet, an advantage over leucine for gastrointestinal symptoms was not established. | 1/4 Very lowA small study with an incomplete or imprecise comparative estimate and reporting limitations. The special tryptophan-restricted diet and active leucine control limit extrapolation to other settings. | 11 studyOral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial. ↗ | 20 healthy volunteers on a tryptophan-restricted diet | - Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial. ↗
|
|---|
| Time awake after sleep onset | In the pooled analysis, time awake after sleep onset was shorter: SMD −1.08; 95% CI −1.89…−0.28. This is a dimensionless standardized difference, not minutes. | 1/4 Very lowSmall studies with incomplete or imprecise comparative estimates; crossover trials were approximately analyzed as parallel-group trials. Different forms, including enriched foods, were pooled; the original assessment limits extrapolation between groups and interventions. | 11 review; 2 publications, 3 comparisons; independence of the groups is not establishedThe impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗ | Adults in short-term sleep studies: with and without insomnia; the group was not exclusively healthy. | - The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗
|
|---|
| Time to fall asleep | No clear pooled difference in time to fall asleep was established: SMD −0.46; 95% CI −1.09…0.18. SMD is dimensionless, not minutes. | 1/4 Very lowSmall studies with incomplete or imprecise comparative estimates; crossover trials were approximately analyzed as parallel-group trials. Different forms, including enriched foods, were pooled; the original assessment limits extrapolation between groups and interventions. | 11 review; 3 publications, 3 comparisons; independence of the groups is not establishedThe impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗ | Adults in short-term sleep studies: with and without insomnia; the group was not exclusively healthy. | - The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗
|
|---|
| Total sleep time | No clear pooled difference in total sleep time was established: SMD 0.29; 95% CI −0.54…1.12. SMD is dimensionless, not hours. | 1/4 Very lowSmall studies with incomplete or imprecise comparative estimates; crossover trials were approximately analyzed as parallel-group trials. Different forms, including enriched foods, were pooled; the original assessment limits extrapolation between groups and interventions. | 11 review; 3 publications, 4 comparisons; independence of the groups is not establishedThe impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗ | Adults in short-term sleep studies: with and without insomnia; the group was not exclusively healthy. | - The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗
|
|---|
| Proportion of time in bed spent asleep | No clear pooled difference in sleep efficiency was established: SMD 1.04; 95% CI −0.11…2.18. SMD is dimensionless, not percentages. | 1/4 Very lowSmall studies with incomplete or imprecise comparative estimates; crossover trials were approximately analyzed as parallel-group trials. Different forms, including enriched foods, were pooled; the original assessment limits extrapolation between groups and interventions. | 11 review; 2 publications, 3 comparisons; independence of the groups is not establishedThe impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗ | Adults in short-term sleep studies: with and without insomnia; the group was not exclusively healthy. | - The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression ↗
|
|---|